Campbell & CO Investment Adviser LLC Novartis Ag Transaction History

Campbell & CO Investment Adviser LLC

$1.24 Billion
Q4 2024

A detailed history of Campbell & CO Investment Adviser LLC transactions in Novartis Ag stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 99,614 shares of NVS stock, worth $10.8 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

99,614

Previous 9,751 921.58%

Holding current value

$10.8 Million

Previous $1.12 Million 764.67%

% of portfolio

0.78%

Previous 0.09%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$96.78 - $117.18 $8.7 Million - $10.5 Million	89,863 Added 921.58%	99,614 $9.69 Million
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $568,326 - $647,365	-5,355 Reduced 35.45%	9,751 $1.12 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $411,195 - $476,937	4,442 Added 41.65%	15,106 $1.61 Million
Q1 2024 May 10, 2024	BUY	$95.27 - $108.47 $733,293 - $834,893	7,697 Added 259.42%	10,664 $1.03 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $273,765 - $301,269	2,967 New	2,967 $299,000
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $488,875 - $554,344	5,284 Added 72.34%	12,588 $1.27 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $584,539 - $677,884	7,304 New	7,304 $671,000
Q1 2020 Apr 29, 2020	SELL	$70.67 - $99.01 $693,555 - $971,684	-9,814 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$84.35 - $95.37 $827,810 - $935,961	9,814 New	9,814 $929,000
Q2 2018 Jul 13, 2018	SELL	$64.91 - $73.36 $357,329 - $403,846	-5,505 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$70.39 - $84.15 $387,496 - $463,245	5,505 New	5,505 $445,000

Others Institutions Holding NVS

# of Institutions

1,474

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Account

Campbell & CO Investment Adviser LLC Novartis Ag Transaction History